BETA

2 Amendments of Anne-Marie MINEUR related to 2018/0161(COD)

Amendment 29 #
Proposal for a regulation
Recital 3 a (new)
(3 a) Whereas the Council has noted with concern that “an increasing number of examples of market failure in a number of Member States, where patients access to effective and affordable essential medicines is endangered by very high and unsustainable price levels […] and that individual governments have sometimes limited influence in such circumstances;”1a __________________ 1a Council conclusions on strengthening the balance in the pharmaceutical systems in the EU and its Member States: https://www.consilium.europa.eu/en/press /press-releases/2016/06/17/epsco- conclusions-balance-pharmaceutical- system/
2018/11/12
Committee: INTA
Amendment 30 #
Proposal for a regulation
Recital 3 b (new)
(3 b) Whereas the European Parliament has expressed that “in many cases, the prices of new medicines have increased during the past few decades to the point of being unaffordable to many European citizens and of threatening the sustainability of national health care systems;”1a __________________ 1a Report on EU options for improving access to medicines (2016/2057(INI): http://www.europarl.europa.eu/sides/getD oc.do?type=REPORT&reference=A8- 2017-0040&language=EN
2018/11/12
Committee: INTA